Amneal Pharmaceuticals Inc Amneal Pharmaceuticals Inc saham

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. The company is headquartered in Bridgewater, New Jersey and currently employs 7,600 full-time employees. The company went IPO on 2009-03-16. The firm specializes in developing, manufacturing, marketing and distributing generic, injectables, biosimilars and branded specialty pharmaceutical products. Its segments include Generics, Specialty, and AvKARE. Its Generics segment includes approximately 250 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system (CNS) disorders, including Parkinson’s disease, and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Prestasi Amneal Pharmaceuticals Inc

  • Pekerja 7600
  • HQ syarikat Bridgewater
  • Laman sesawang
  • Jenis Aset AMRX Common Stock
  • Permodolan Pasaran AMRX 2.3B
  • Pendapatan per Saham -0.73
  • Dividen per Saham None
  • Tarikh Dividen None
  • Pertumbuhan Pendapatan Suku Tahun -0.949

Berminat dengan Amneal Pharmaceuticals Inc? Anda mungkin berminat dengan: